Drug regulatory bodies should only evaluate whether phar
Drug regulatory bodies should only evaluate whether phar
Drug regulatory bodies should only evaluate whether pharFull motion: Drug regulatory bodies (e.g. FDA, EMA, MHRA) should only evaluate whether pharmaceuticals (e.g. treatments, medicines, vaccines) are safe, but not whether they are effective
jazyk: en
teze: Drug regulatory bodies should only evaluate whether pharmaceuticals are safe, but not whether they are effective
krátký text: effective pharmaceuticals
| datum | aff | neg | výsledek | |
|---|---|---|---|---|
| 2024-04-27 | Kamisaki | Edgar Allan Hoe$ | neg 3:0 | více |
| 2024-04-27 | | Malakas | neg 3:0 | více |
| 2024-04-27 | Šlapáci a Šlapky | Colloquium strachu | neg 3:0 | více |
Průměr výsledku (balloty aff:neg): 0.0000:3.0000